HEALTHEAST ST JOSEPHS HOSPITAL
1. Target Overview & Investment Thesis
HEALTHEAST ST JOSEPHS HOSPITAL is a 28-bed under-performing / distressed in RAMSEY, MN with $8.5M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 20.1% Medicare, 2.5% Medicaid, and 77.4% commercial.
Thesis: Turnaround. Our ML models identify $632K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -179.9% (+745bps).
| Net Revenue HCRIS | $8.5M |
| Current EBITDA COMPUTED | $-15.9M |
| Operating Margin COMPUTED | -100.0% |
| Occupancy HCRIS | 55.8% |
| Revenue / Bed COMPUTED | $303K |
| Net-to-Gross HCRIS | 27.6% |
| Distress Probability ML | 46.9% |
2. Market Context & Competitive Position
MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -100.0% places it below the state median. Among 94 size-comparable peers (14-56 beds), the median margin is -1.8%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (14-56), prioritizing same-state peers. 94 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HEALTHEAST ST JOSEPHS HOSPITAL (Target) | MN | 28 | $8.5M | -100.0% |
| CUYUNA REGIONAL MEDICAL CENTER | MN | 25 | $180.8M | -4.0% |
| ST. MARYS REGIONAL HEALTH CENT | MN | 36 | $167.8M | 3.1% |
| MAYO CLINIC HEALTH SYSTEM - RE | MN | 27 | $149.3M | 1.8% |
| ESSENTIA HEALTH VIRGINIA | MN | 49 | $132.0M | -5.0% |
| NEW ULM MEDICAL CENTER | MN | 24 | $128.6M | 4.2% |
| LAKEWOOD HEALTH SYSTEM | MN | 25 | $124.7M | 0.2% |
| NORTHFIELD CITY HOSPITAL | MN | 37 | $121.8M | -8.4% |
| FAIRVIEW LAKES REGIONAL MEDICA | MN | 55 | $119.6M | 10.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $632K (745bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $178K | +210bp | 18mo |
| Denial Rate Reduction | 12.0% | 6.5% | $172K | +202bp | 12mo |
| Cost to Collect | 4.5% | 2.5% | $170K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $103K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +11bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-15.9M |
| + RCM Uplift | +$632K |
| Pro Forma EBITDA | $-15.3M |
| Current Margin | -100.0% |
| Pro Forma Margin | -179.9% |
| WC Released (1x) | $325K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-24.5M | $-98.5M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-24.5M | $-116.3M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-22.0M | $-122.2M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-22.0M | $-139.8M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-26.9M | $-93.7M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-26.9M | $-111.9M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 94 hospitals with 14-56 beds
- Same-state prioritization (n=95)
- Comp margins: P25=-8.5% / P50=-1.8% / P75=3.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.